Attached files

file filename
EX-99 - EXHIBIT 99 - CHEMED CORPa50809409ex99.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 8-K
CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (date of earliest event reported):
February 21, 2014


CHEMED CORPORATION
(Exact name of registrant as specified in its charter)

Delaware

1-8351

31-0791746

(State or other

jurisdiction of

incorporation)

(Commission File Number)

(I.R.S. Employer

Identification

Number)

2600 Chemed Center, 255 East 5th Street, Cincinnati, OH 45202

(Address of principal executive offices)           (Zip Code)


Registrant’s telephone number, including area code:
(513) 762-6500


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Page 1 of 2

Item 8.01     Other Events

On February 21, 2014 Chemed Corporation issued a press release announcing that its Board of Directors increased the authorization of Chemed’s share repurchase program to provide for $100 million of future share repurchases.  These will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility.  A copy of the release is filed herewith as Exhibit 99

Item 9.01     Financial Statements and Exhibits

d)        Exhibit

(99) Registrant’s press release dated February 21, 2014




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CHEMED CORPORATION

 

 

Dated:

February 21, 2014

By:

/s/  Arthur V. Tucker Jr.

 

Arthur V. Tucker, Jr.

 

Vice President and Controller


Page 2 of 2